TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31213045

Group type: EXPERIMENTAL
Intervention: Dynamic needle tip positioning (DNTP)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional long-axis in-plane (LAX-IP)
Number of subjects: 136
Study: 30676790

Group type: EXPERIMENTAL
Intervention: Cesarean delivery during the 1-child policy period (January 2013-September 2014)
Number of subjects: 27977

Group type: EXPERIMENTAL
Intervention: Cesarean delivery during the selective 2-child policy period (October 2014-July 2016)
Number of subjects: 27977

Group type: EXPERIMENTAL
Intervention: Cesarean delivery during the universal 2-child policy period (August 2016-December 2016)
Number of subjects: 27977

Group type: EXPERIMENTAL
Intervention: Cesarean delivery on maternal request
Number of subjects: 27977

Group type: EXPERIMENTAL
Intervention: Cesarean delivery indicated by a previous cesarean delivery
Number of subjects: 27977

Group type: EXPERIMENTAL
Intervention: Assessment of medical necessity of cesareans by experts
Number of subjects: 27977
Study: 27459673

Group type: EXPERIMENTAL
Intervention: Altitude training at 2200m (ALT, n = 5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group at 600m (CON, n = 5)
Number of subjects: 10
Study: 26040302

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 494
Study: 23549424

Group type: EXPERIMENTAL
Intervention: Endovascular repair (EVAR)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Nonrandomized cohort (surgically treated patients)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Open repair (OR) in patients with unfavorable anatomy for EVAR
Number of subjects: 116
Study: 21551987

Group type: EXPERIMENTAL
Intervention: Fall prevention program (12-week group program and 8-week self-management program using a health calendar)
Number of subjects: 53
Study: 19758429

Group type: EXPERIMENTAL
Intervention: Blue-collar/housewife status
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: BMI > or = 30 kg/m2
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Sibling history of CTS
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Coexistence of trigger finger
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Height (women > or = 165 cm; men > or = 175 cm)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Combinations of biomechanical risk factors (frequent repetitivity and sustained force)
Number of subjects: 220
Study: 17227802

Group type: EXPERIMENTAL
Intervention: Oral alendronate 70 mg/wk
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 14633757

Group type: EXPERIMENTAL
Intervention: i.v. midazolam sedation (titrated at 0.5 mg x min(‐1), maximum 5 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitrous oxide/oxygen sedation (titrated to 30%/70%)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: i.v. midazolam sedation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitrous oxide/oxygen sedation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 40
Study: 10947321

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Jet Nebulizer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patient Preference
Number of subjects: 20
Study: 8648308

Group type: EXPERIMENTAL
Intervention: Cementless total knee arthroplasty in obese patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (nonobese patients)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Both groups (obese and control)
Number of subjects: 45
Study: 1613808

Group type: EXPERIMENTAL
Intervention: Systemic hypothermia (cooling to 30-32 degrees C for 1-8 hours, mean 4 hours)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cooling to levels below 32 degrees C
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Routine potassium replacement for asymptomatic hypokalemia
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Surface cooling to a core temperature of 32 degrees C for 48 hours
Number of subjects: 21
Study: 6378239

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (RIT 4199)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cold-adapted recombinant virus vaccine (A/Washington/80, H3N2)
Number of subjects: 29
Study: 30078335

Group type: EXPERIMENTAL
Intervention: Personalized environmental report back intervention (free air nicotine and radon home test kits, brief problem-solving phone intervention)
Number of subjects: 515

Group type: COMPARATOR
Intervention: Control group (coupon for free test kits)
Number of subjects: 515
Study: 28158398

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study: 25925687

Group type: EXPERIMENTAL
Intervention: Tacrolimus withdrawal
Number of subjects: 14
Study: 23913722

Group type: EXPERIMENTAL
Intervention: Deferring control to God
Number of subjects: 192

Group type: COMPARATOR
Intervention: Active coping style
Number of subjects: 192
Study: 21802625

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma fibrin matrix (PRPFM) construct augmentation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rotator cuff repairs without PRPFM augmentation (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: American Shoulder and Elbow Surgeons score
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single Assessment Numeric Evaluation score
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Simple Shoulder Test score
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Constant score
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rowe score
Number of subjects: 40
Study: 19254354

Group type: COMPARATOR
Intervention: 300 mg Acotiamide
Number of subjects: 71

Group type: COMPARATOR
Intervention: 100 mg Acotiamide
Number of subjects: 71
Study: 16896273

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg and Atorvastatin 10 mg
Number of subjects: 847

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 847

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 847

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 847
Study: 15145925

Group type: EXPERIMENTAL
Intervention: Exercise (90 min cycling at 85% lactate threshold)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rest (semirecumbent)
Number of subjects: 20
Study: 10900369

Group type: EXPERIMENTAL
Intervention: Transmural home care intervention programme
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 116
Study: 9310278

Group type: EXPERIMENTAL
Intervention: Fish oil (eicosapentaenoic acid, 1.08 g/day)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Mustard oil (alpha-linolenic acid, 2.9 g/day)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 8449054

Group type: EXPERIMENTAL
Intervention: Clarithromycin, 250 mg twice a day for 7 to 14 days
Number of subjects: 268

Group type: COMPARATOR
Intervention: Erythromycin stearate, 500 mg 4 times a day for 7 to 14 days
Number of subjects: 268
Study: 3819391

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg t.i.d. for 3 days
Number of subjects: 10
Study: 29064206

Group type: EXPERIMENTAL
Intervention: 500 mg vitamin B3 daily for 1 week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 28854066

Group type: EXPERIMENTAL
Intervention: Eribulin (1.4 mg/m2 intravenously on days 1 and 8 every 21 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dacarbazine (850, 1,000, or 1,200 mg/m2 intravenously on day 1 every 21 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dacarbazine
Number of subjects: 0
Study: 25953506

Group type: COMPARATOR
Intervention: Conventional shoes (CONV)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Minimalistic shoes (MIN)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fatigued state
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 26
Study: 23477634

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 20211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20211
Study: 21320346

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment of malaria in infants (IPTi) with sulphadoxine‐pyrimethamine (SP) administered at the time of routine vaccinations.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-implementing health centres (Control)
Number of subjects: 0
Study: 19223984

Group type: EXPERIMENTAL
Intervention: 4 kcal/kg/week exercise (n = 139)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: 8 kcal/kg/week exercise (n = 85)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: 12 kcal/kg/week exercise (n = 93)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Non-exercise control (n = 94)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: All exercise groups
Number of subjects: 411
Study: 16543297

Group type: EXPERIMENTAL
Intervention: Training and support intervention delivered to nursing home staff over 10 months, focusing on alternatives to drugs for the management of agitated behaviour in dementia
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control homes
Number of subjects: 12
Study: 14767435

Group type: EXPERIMENTAL
Intervention: AIC (0.06-12 microg, n = 28)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 57
Study: 11168210

Group type: EXPERIMENTAL
Intervention: Implant-retained mandibular overdenture (IRO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Preprosthetic surgery to enlarge the denture‐bearing area (PPS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Construction of a new set of dentures (CD)
Number of subjects: 90
Study: 9399292

Group type: EXPERIMENTAL
Intervention: Diet and/or exercise intervention during 1990-1991
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Current physical self-perceptions
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-perception model, Health Belief model, Self-efficacy model
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Outcome Expectations, Compliance Self-efficacy, Perceived Fitness, Exercise Mastery
Number of subjects: 200
Study: 8250308

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine added to general anesthesia
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standardized general anesthesia (control group)
Number of subjects: 22
Study: 3307423

Group type: EXPERIMENTAL
Intervention: Frequent nursing contact, education in preterm labor symptoms, and self‐palpation of uterine activity (group E, n = 50)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Daily nursing contact, preterm labor education, and the Term Guard home uterine activity monitor (group EM, n = 107)
Number of subjects: 157
Study: 30322751

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.4 (500 mL bolus)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ringer's acetate (1000 mL bolus)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ringer's acetate (control group)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.4
Number of subjects: 43
Study: 28835401

Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Number of subjects: 0
Study: 26420182

Group type: EXPERIMENTAL
Intervention: Encapsulated kiwifruit extract (1 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23957631

Group type: EXPERIMENTAL
Intervention: Synbiotic (Bifidobacterium longum and inulin-based prebiotic Synergy 1)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 43
Study: 21402860

Group type: EXPERIMENTAL
Intervention: 200‐mg rifamycin SV MMX modified‐release tablets
Number of subjects: 2
Study: 18496232

Group type: EXPERIMENTAL
Intervention: Prednisolone (1 mg/kg/d)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg/d)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Prednisolone (after switching from Budesonide)
Number of subjects: 22
Study: 16569361

Group type: EXPERIMENTAL
Intervention: 50mg Etanercept BIW
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 100mg Etanercept OW
Number of subjects: 108
Study: 12714403

Group type: COMPARATOR
Intervention: Viscocanalostomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Viscocanalostomy with reticulated hyaluronic acid implant (VSRHAI)
Number of subjects: 40
Study: 10886700

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 32

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 32
Study: 7486361

Group type: EXPERIMENTAL
Intervention: BiPAP (n = 60)
Number of subjects: 100

Group type: COMPARATOR
Intervention: SVN (n = 40)
Number of subjects: 100
Study: 2366020

Group type: EXPERIMENTAL
Intervention: Standard and positional views of normal wrists under stress
Number of subjects: 53

Group type: COMPARATOR
Intervention: Injured wrists with pathological roentgenographic appearances
Number of subjects: 53
Study: 36422

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31774408

Group type: EXPERIMENTAL
Intervention: Chatbot (Vik)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Physicians
Number of subjects: 142
Study: 28610884

Group type: EXPERIMENTAL
Intervention: Surgical AVR
Number of subjects: 2138
Study: 26999924

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.003 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intrathecal morphine)
Number of subjects: 46
Study: 23827330

Group type: EXPERIMENTAL
Intervention: sodium nitrate (NaNO3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: sodium chloride (NaCl) (saline placebo)
Number of subjects: 20
Study: 21801403

Group type: EXPERIMENTAL
Intervention: AMG 108 (300 mg SC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 18329883

Group type: EXPERIMENTAL
Intervention: Fixed-bearing (FB) total knee arthroplasty
Number of subjects: 102

Group type: COMPARATOR
Intervention: Mobile-bearing (MB) total knee arthroplasty
Number of subjects: 102
Study: 16520527

Group type: EXPERIMENTAL
Intervention: Receipt of public benefits, health insurance coverage, moderate social support, avoidance of illegal activity, HIV seropositivity
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Receipt of public benefits, hospitalization, primary care, avoiding re-arrest
Number of subjects: 511

Group type: COMPARATOR
Intervention: Chronic diseases (diabetes, asthma, depression)
Number of subjects: 511
Study: 12828691

Group type: EXPERIMENTAL
Intervention: Four single-pass treatments at 2-week intervals
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Four double-pass treatments at 2-week intervals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both treatment methods (single-pass and double-pass)
Number of subjects: 20
Study: 10853619

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 10 mg/kg (as caffeine base) administered intravenously, followed by 2.5 mg/kg/day orally or intravenously, for up to 10 days.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 9394698

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber diet (LFHFD)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Low-fat, low-fiber diet (LFLFD)
Number of subjects: 31
Study: 8497683

Group type: EXPERIMENTAL
Intervention: ONO‐1078 (225 mg twice a day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2448863

Group type: EXPERIMENTAL
Intervention: Combined CDDP‐5 FU
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: CDDP‐BLM‐VCR‐MTX
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: CDDP‐BLM‐VDS
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Small tumors (T1, T2)
Number of subjects: 135
Study: 29275502

Group type: EXPERIMENTAL
Intervention: 21-gauge needle
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 23-gauge needle
Number of subjects: 88
Study: 25539597

Group type: EXPERIMENTAL
Intervention: Complete CYD final report
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Personalized feedback components of the CYD
Number of subjects: 741

Group type: COMPARATOR
Intervention: Normative feedback components of the CYD
Number of subjects: 741

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 741
Study: 22859357

Group type: EXPERIMENTAL
Intervention: Celecoxib 50 mg bid
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Celecoxib 800/400 mg
Number of subjects: 400

Group type: COMPARATOR
Intervention: Indomethacin 50 mg tid
Number of subjects: 400
Study: 20159250

Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 13542

Group type: COMPARATOR
Intervention: Non-LABA
Number of subjects: 13542
Study: 18672985

Group type: EXPERIMENTAL
Intervention: Ridge-preservation procedure with corticocancellous porcine bone and collagen membrane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Extraction alone
Number of subjects: 40
Study: 15877867

Group type: EXPERIMENTAL
Intervention: Tomato juice (330 ml/d, 37.0 mg lycopene, 1.6 mg beta-carotene) for 2 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Carrot juice (330 ml/d, 27.1 mg beta-carotene, 13.1 mg alpha-carotene) for 2 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Baseline comparison of lag time
Number of subjects: 22
Study: 12929855

Group type: EXPERIMENTAL
Intervention: Deltamethrin-treated mosquito nets, mosquito repellent cream, and weekly chemoprophylaxis with 300 mg chloroquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control measures prior to intervention
Number of subjects: 0
Study: 10391671

Group type: EXPERIMENTAL
Intervention: 12.5 mg rofecoxib
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 25 mg rofecoxib
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 8730609

Group type: EXPERIMENTAL
Intervention: Rapeseed oil (RO) diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trisun-sunflower oil (TSO) diet
Number of subjects: 40
Study: 1486963

Group type: EXPERIMENTAL
Intervention: Piretanide (24 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Frusemide (40 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 4037215

Group type: EXPERIMENTAL
Intervention: Neuroleptic (Droperidol)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No neuroleptic (Control group)
Number of subjects: 58
Study: 30895893

Group type: EXPERIMENTAL
Intervention: Positive image appeal with low descriptive norm
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Negative image appeal with low descriptive norm
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Positive image appeal with high descriptive norm
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Negative image appeal with high descriptive norm
Number of subjects: 204
Study: 29320549

Group type: EXPERIMENTAL
Intervention: Intra-articular botulinum toxin A (30 IU)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 27011305

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Pneumatic Compression
Number of subjects: 72

Group type: COMPARATOR
Intervention: Supine Rest
Number of subjects: 72
Study: 24667502

Group type: EXPERIMENTAL
Intervention: Dissection-based training using laparoscopic dissection models
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dissection-based laparoscopic training
Number of subjects: 46

Group type: COMPARATOR
Intervention: Lectures only (Group I)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combination of lectures and dissection-based laparoscopic training (Group III)
Number of subjects: 46
Study: 22193388

Group type: EXPERIMENTAL
Intervention: Epoetin-β to normalize hemoglobin values (13.0-15.0 g/dl)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Partial correction of anemia (10.5-11.5 g/dl)
Number of subjects: 125
Study: 20447533

Group type: EXPERIMENTAL
Intervention: Global thrombosis test (GTT) assessing lysis time (LT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Global thrombosis test (GTT) assessing occlusion time (OT)
Number of subjects: 300
Study: 18843939

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo or typical/atypical antipsychotics
Number of subjects: 0
Study: 15889606

Group type: EXPERIMENTAL
Intervention: Paula Garburg sphincter muscle exercises combined with Young vaginal dilators
Number of subjects: 60

Group type: COMPARATOR
Intervention: Masters and Johnson's desensitization approach combined with Young vaginal dilators
Number of subjects: 60
Study: 12638308

Group type: EXPERIMENTAL
Intervention: Estrogen deficiency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guidelines for hypertension management
Number of subjects: 0
Study: 10574854

Group type: EXPERIMENTAL
Intervention: 30% glucose
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 30% sucrose
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: pacifier
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 30% sucrose plus pacifier
Number of subjects: 150

Group type: COMPARATOR
Intervention: placebo (sterile water)
Number of subjects: 150

Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 150
Study: 8933994

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1806622

Group type: EXPERIMENTAL
Intervention: Flosequinan (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7063809

Group type: EXPERIMENTAL
Intervention: Fasting
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lactovegetarian diet
Number of subjects: 5
Study: 31451854

Group type: EXPERIMENTAL
Intervention: Desmopressin nasal spray
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 30